Paper35537606
FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model.
Tinganelli W and 10 others. Radiother Oncol, 2022. Cited by 103 papers, by iCite.
Cite this record
ConductScience Library. FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model. Papers, record 35537606. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35537606
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- FLASH with carbon ions: Tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Osteosarcoma | Major topic |
| Lung Neoplasms | Major topic |
| Bone Neoplasms | Major topic |
| Female | |
| Mice | |
| Animals | |
| Radiotherapy Dosage | |
| Protons | |
| Carbon | |
| Mice, Inbred C3H |
Source PubMed
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 103 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909922 | Ultra-high-dose-rate pulsed irradiation and the conditional FLASH effect: dosimetry, multiscale biology, and clinical translation. | Front Oncol | 2026 | https://conductscience.org/library/papers/42909922 | PubMed |
| 42882427 | Harnessing Particle Ions for FLASH Radiotherapy. | Cells | 2026 | https://conductscience.org/library/papers/42882427 | PubMed |
| 42837388 | Expanding dose and dose-rate capabilities of a synchrotron-based pre-clinical proton FLASH irradiation platform. | Med Phys | 2026 | https://conductscience.org/library/papers/42837388 | PubMed |
| 42777776 | Physicochemical modeling of electron FLASH to identify the roles of oxygen, aqueous electrons and causal radical recombination effects underlying them. | Phys Med Biol | 2026 | https://conductscience.org/library/papers/42777776 | PubMed |
| 42662452 | FLASH radiotherapy as an emerging paradigm in radioimmunotherapy: biological rationale, preclinical evidence, and translational roadmap. | Front Immunol | 2026 | https://conductscience.org/library/papers/42662452 | PubMed |
| 42625213 | FLASH radiotherapy: physico-chemical considerations on ionisation tracks, radical reactions, and the role of oxygen. | Radiat Oncol | 2026 | https://conductscience.org/library/papers/42625213 | PubMed |
| 42591138 | Global clinical landscape and multidisciplinary translational frontiers of FLASH radiotherapy: a systematic review and visualized bibliometric mapping based on WoSCC and PubMed (2014-2025). | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42591138 | PubMed |
| 42549040 | Harnessing the sparing effect of FLASH-RT: From phenomenon observation, radiophysical determinants to molecular mechanisms and synergistic strategies. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42549040 | PubMed |
| 42459836 | Microenvironmental remodeling in FLASH radiotherapy. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42459836 | PubMed |
| 42235691 | Musculoskeletal and Marrow Sparing With Proton FLASH Radiation Therapy in Juvenile Mice. | Int J Radiat Oncol Biol Phys | 2026 | https://conductscience.org/library/papers/42235691 | PubMed |
| 42234857 | For ultra-high dose rate carbon-ion irradiation, comparable beam parameters induce the equivalent cell sparing (FLASH) effect. | J Radiat Res | 2026 | https://conductscience.org/library/papers/42234857 | PubMed |
| 42101631 | Redox-modulation of regulated cell death: implications for synergistic anticancer therapies. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42101631 | PubMed |
| 42005556 | Advancing Particle Therapy to Improve Cancer Care: Report on "2nd World Forum on Particle Therapy". | Int J Part Ther | 2026 | https://conductscience.org/library/papers/42005556 | PubMed |
| 41898709 | Physiologically Relevant Organotypic Tissue Slice Model for Evaluating Cell Responses to Ionizing Radiation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898709 | PubMed |
| 41890242 | The potential and risks of FLASH radiotherapy in pediatric patients. | Neurooncol Pediatr | 2026 | https://conductscience.org/library/papers/41890242 | PubMed |
| 41866638 | Research progresses on FLASH radiotherapy and its application for the treatment of digestive system tumors. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41866638 | PubMed |
| 41809499 | FLASH: New intersection of physics, chemistry, biology, and cancer medicine. | Rev Mod Phys | 2024 | https://conductscience.org/library/papers/41809499 | PubMed |
| 41423134 | Deliverable proton conformal FLASH radiotherapy treatment planning for head and neck re-irradiation patients. | Radiother Oncol | 2026 | https://conductscience.org/library/papers/41423134 | PubMed |
| 41372430 | Carbon ion FLASH irradiation reduces acute skin toxicity compared with conventional dose rate irradiation. | Sci Rep | 2025 | https://conductscience.org/library/papers/41372430 | PubMed |
| 41316325 | Partial abdominal carbon-ion FLASH irradiation spares lethality compared to conventional irradiation: impact of LET and dose rate. | Radiat Oncol | 2025 | https://conductscience.org/library/papers/41316325 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35537606
GET https://conductscience.org/api/papers/v1/35537606/cited_by?page=2